Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies

ABSTRACTPURPOSE: Systemic, immune, and target therapies are growing in use in the management of metastatic cancers. The aim of this review was to describe up-to-date published data on the safety and tolerability of metastasis-directed hypofractionated radiation therapy (RT) when combined with newer...

Descripción completa

Detalles Bibliográficos
Autores principales: Guimond, Elizabeth, Tsai, Chiaojung Jillian, Hosni, Ali, O'Kane, Grainne, Yang, Jonathan, Barry, Aisling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Critical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513086/
https://www.ncbi.nlm.nih.gov/pubmed/36177487
http://dx.doi.org/10.1016/j.adro.2022.101022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513086/
https://www.ncbi.nlm.nih.gov/pubmed/36177487
http://dx.doi.org/10.1016/j.adro.2022.101022

Ejemplares similares